Recombinant PtlD is a full-length, His-tagged version of the native PtlD protein (UniProt ID: Q7VSX8) expressed in E. coli. It corresponds to amino acids 25–463 of the mature protein and is essential for stabilizing the Ptl transporter, a type IV secretion system (T4SS) in B. pertussis .
| Property | Description |
|---|---|
| Source | Bordetella pertussis |
| Expression Host | Escherichia coli |
| Tag | N-terminal His tag |
| Protein Length | 439 amino acids (25–463) |
| Purity | >90% (SDS-PAGE) |
| Storage | Lyophilized powder in Tris/PBS buffer, pH 8.0, with 6% trehalose |
PtlD is one of nine Ptl proteins (PtlA–PtlI) forming the T4SS that secretes pertussis toxin . It stabilizes the transporter by maintaining the integrity of PtlE, PtlF, and PtlH .
C-terminal region (aa 392–463): Necessary for stabilizing PtlE, PtlF, and PtlH but insufficient for toxin secretion .
Core functional motif (aa 425–434): A 10-amino-acid stretch critical for transporter stability .
PtlD acts as a scaffold for the transporter complex. Deletion of its C-terminal 72 amino acids destabilizes PtlE, PtlF, and PtlH, impairing PT secretion .
KEGG: bpe:BP3791
STRING: 257313.BP3791
PtlD is an essential component of the type IV secretion system (T4SS) in Bordetella pertussis that facilitates the export of pertussis toxin (PT) across the bacterial outer membrane. Research has demonstrated that PtlD plays a critical role in maintaining the structural integrity of the secretion apparatus by stabilizing other proteins in the Ptl transporter complex, particularly PtlE, PtlF, and PtlH. Without functional PtlD, pertussis toxin cannot be effectively secreted from the bacterium into the extracellular environment, significantly impacting bacterial virulence .
The Ptl transporter system comprises nine different proteins (PtlA through PtlI) that work together to form a functional type IV secretion apparatus. PtlD functions as a stabilizing component for at least three other Ptl proteins: PtlE (a VirB8 homologue), PtlF (a VirB9 homologue), and PtlH (a VirB11 homologue). Experimental evidence shows that deletion of ptlD results in significant decreases in the detectable amounts of these proteins in bacterial cells. This suggests that PtlD serves as a structural scaffold that prevents the degradation of key components of the secretion machinery .
PtlD is a homologue of VirB6, a component found in other bacterial type IV secretion systems. Comparative studies with the VirB system reveal that deletion of virB6 similarly results in reductions of VirB8, VirB9, and VirB11 protein levels under conditions that favor protein turnover. This evolutionary relationship suggests conserved functions across different bacterial species and provides valuable insights for researchers studying the broader family of type IV secretion systems. Phylogenetic analysis of PtlD can help identify conserved functional domains and potential therapeutic targets .
Creating precise in-frame ptlD deletion mutants requires careful design of PCR primers and selection strategies. Based on published methodologies, researchers should:
Design PCR primers to amplify regions flanking the ptlD gene
Ligate these fragments to create a deletion construct
Insert the construct into a suitable vector (e.g., pSS1129 as used in published studies)
Introduce the construct into B. pertussis through conjugation
Select for homologous recombination events using appropriate antibiotics
Verify deletion by PCR and sequencing
This approach ensures clean deletion of ptlD while maintaining the reading frame, allowing for precise functional studies without polar effects on downstream genes .
For optimal detection and quantification of PtlD and its interacting partners:
Generate specific antibodies against purified recombinant PtlD protein
Use immunoblotting (Western blot) for protein detection
Apply densitometric analysis of replicate immunoblots from independent experiments for quantification
Employ statistical methods such as Tukey's honestly significant difference test following analysis of variance to determine significance
Consider co-immunoprecipitation to study direct protein-protein interactions
For enhanced sensitivity, complement immunodetection with mass spectrometry-based proteomics
These approaches allow for reliable assessment of protein stability and interactions in both wild-type and mutant strains .
For successful expression and purification of recombinant PtlD:
Clone the ptlD gene or specific domains into expression vectors with appropriate tags (His6, GST, or MBP tags can improve solubility)
Express in E. coli systems optimized for membrane proteins (e.g., C41(DE3) or C43(DE3) strains)
Use mild detergents for solubilization (DDM, LDAO, or OG depending on downstream applications)
Purify using affinity chromatography followed by size-exclusion chromatography
Verify protein quality by SDS-PAGE and Western blotting
Assess protein folding using circular dichroism spectroscopy
For difficult-to-express constructs, consider cell-free expression systems or expression in alternative hosts
Remember that as a membrane-associated protein, PtlD can present challenges for recombinant expression and may require optimization of conditions to maintain native conformation.
The C-terminal region of PtlD (amino acids 392-463) is sufficient for maintaining the stability of interacting Ptl proteins, indicating this domain is crucial for protein-protein interactions. Research has further demonstrated that a specific 10-amino acid stretch (amino acids 425-434) makes significant contributions to this stabilizing function. To investigate domain-specific interactions:
Generate truncated versions of PtlD with progressive deletions
Express these constructs in ptlD deletion strains
Assess the stability of PtlE, PtlF, and PtlH by immunoblotting
Use bacterial two-hybrid systems to detect direct protein interactions
Apply cross-linking followed by mass spectrometry to map interaction interfaces
Perform mutagenesis of conserved residues within the C-terminal domain to identify critical amino acids
These approaches can help create a detailed map of interaction interfaces and guide structural biology efforts .
Understanding the assembly pathway of the Ptl transporter requires sophisticated approaches:
Develop inducible expression systems for individual Ptl components
Establish pulse-chase experiments with immunoprecipitation to track protein assembly
Apply time-resolved crosslinking to capture assembly intermediates
Use fluorescently tagged Ptl proteins with FRET analysis to monitor real-time interactions
Employ single-particle cryo-EM to visualize assembly intermediates
Utilize hydrogen-deuterium exchange mass spectrometry to identify dynamic interaction regions
Develop quantitative proteomics approaches to measure stoichiometry during assembly
These methods can reveal the sequence of events in Ptl complex formation and identify rate-limiting steps that might serve as intervention points.
Investigating the energetic contributions of PtlD requires:
Design ATP hydrolysis assays to measure energy consumption in wild-type versus ptlD mutant strains
Create point mutations in potential energy-coupling domains
Perform isothermal titration calorimetry to measure binding energetics between PtlD and other components
Develop real-time secretion assays using fluorescently labeled pertussis toxin
Measure proton motive force utilization in secretion-competent versus incompetent strains
Apply computational modeling to predict energy transfer pathways through the Ptl complex
Understanding these energetic contributions could reveal how the system converts chemical energy into mechanical work for toxin translocation.
To differentiate between these functions:
Create chimeric proteins where the C-terminal stabilizing domain (amino acids 392-463) is fused to heterologous membrane anchors
Assess whether these constructs restore PtlE, PtlF, and PtlH stability without supporting toxin secretion
Develop in vitro reconstitution systems with purified components to test direct interactions with toxin subunits
Apply site-specific crosslinking to detect transient interactions between PtlD and toxin during secretion
Use electron microscopy to visualize structural changes in the secretion apparatus with wild-type versus truncated PtlD
These experiments can help determine whether PtlD plays additional roles beyond stabilizing other Ptl proteins .
For accurate membrane topology mapping:
Generate reporter fusions (PhoA/LacZ) at various positions within PtlD
Apply site-specific labeling with membrane-impermeant reagents
Use protease accessibility assays in spheroplasts versus intact cells
Perform cryo-electron tomography on bacterial membranes containing the Ptl complex
Apply molecular dynamics simulations to predict stable membrane-embedded conformations
Use EPR spectroscopy with spin-labeled cysteines to determine accessibility in lipid environments
Topology information is crucial for understanding how PtlD interacts with both the membrane and other Ptl components.
To investigate substrate recognition functions:
Perform co-purification experiments between PtlD and pertussis toxin subunits
Create chimeric toxins with altered potential recognition motifs
Develop in vitro binding assays using surface plasmon resonance or microscale thermophoresis
Conduct targeted mutagenesis of conserved residues in potential substrate-binding regions
Apply photo-crosslinking with unnatural amino acids to capture transient interactions
Use computational docking to predict potential interaction interfaces
Perform deep mutational scanning of both PtlD and toxin subunits to identify critical interaction residues
These approaches can reveal whether PtlD directly participates in substrate recognition or primarily serves a structural role.
To assess the impact of PtlD mutations on virulence:
Generate B. pertussis strains with targeted mutations in the C-terminal domain (especially amino acids 425-434)
Measure toxin secretion levels in vitro using ELISA or functional assays
Assess bacterial colonization in respiratory infection models
Quantify immune responses to infection with mutant versus wild-type strains
Evaluate histopathological changes in respiratory tissues
Perform competitive infection experiments between wild-type and mutant strains
Correlate specific mutations with changes in disease severity and duration
This research direction provides valuable insights into structure-function relationships with direct relevance to pathogenesis .
For inhibitor discovery and development:
Establish high-throughput screening assays for PtlD stabilizing function
Develop fluorescence-based real-time assays for toxin secretion
Design fragment-based screens targeting the critical C-terminal domain
Apply structure-based virtual screening if structural data becomes available
Assess peptide mimetics of the essential 10-amino acid region (425-434)
Evaluate natural product libraries for compounds that destabilize the Ptl complex
Develop cell-based assays to identify inhibitors with appropriate permeability
This research has translational potential for developing novel therapeutic approaches against pertussis.
For comparative analysis:
Perform multiple sequence alignment of PtlD with VirB6 homologues from diverse bacteria
Generate phylogenetic trees to map evolutionary relationships
Identify conserved versus variable regions that might indicate functional specialization
Conduct complementation experiments by expressing heterologous VirB6-like proteins in ptlD deletion strains
Develop chimeric proteins swapping domains between PtlD and other VirB6 homologues
Compare protein-protein interaction networks across different T4SS systems
Use structural prediction algorithms to identify potential functional convergence despite sequence divergence
This comparative approach places PtlD research in a broader context of bacterial secretion system evolution and function .